![]() |
|
![]() |
Respiratory Syncytial Virus InfectionRespiratory syncytial virus infection occurs almost exclusively in infants and young children. It's the leading of lower respiratory tract infections, pneumonia, tracheobronchitis, and bronchiolitis in this age group. It's also a suspected cause of the fatal respiratory diseases of infancy. Rates of illness are highest among infants age 1 to 6 month; incidence peaks between 2 and 3 months. Those day-care settings are especially susceptible. The virus creates annual epidemics during winter and spring. CausesRSV infection is caused by a virus that attacks the respiratory tract—the nose, eyes, throat, and lungs. Infection spreads from person to person through everyday contact. The virus is most often spread by sharing food or drink with an infected person or by getting droplets containing the virus on your hands and then touching your eyes, nose, or mouth. The incubation period—the time from exposure to RSV until you develop symptoms—ranges from 2 to 8 days, but usually is 4 to 6 days. Symptoms and Signs
Diagnostic testsCultures of nasal and pharyngeal secretions may show respiratory syncytial virus; however, the virus is very labile, so cultures aren't always reliable. Serum antibody titers may be elevated, but in infants under age 4 months, maternal antibodies may impair test results. Two serologic techniques that give rapid results are indirect immunofluorescence and the enzymelinked immunosorbent assay (ELISA). However, these tests are an impractical diagnostic tool because serum specimens aren't obtained until 4 weeks after the onset of illness. They're mainly used for epidemiologic studies. TreatmentAppropriate treatment aims to support respiratory function, maintain fluid balance, and relieve symptoms. Ribavirin, a broad-spectrum antiviral agent, is being used successfully to treat infants with severe lower respiratory tract infection caused by the respiratory syncytial virus. The aerosol form of the drug is given by way of tent, oxygen hood, mask, or ventilator for 2 to 5 days, 12 to 18 hours a day. With this drug therapy, patients show less severe symptoms and improvements in arterial oxygen saturation. Prevention
|
© Doctor-clinic.org. All rights reserved. Bookmark This Page: Disclaimer :- The materials in this web site are in no way intended to replace the professional medical care, advice, diagnosis or treatment of a doctor. The web site does not have answers to all problems. Answers to specific problems may not apply to everyone. If you notice medical symptoms or feel ill, you should consult your doctor . We will not be liable for any complications or other medical accidents arising from or in connection with the use of or reliance upon any information in this web site. |